Altered Retinoic Acid Sensitivity and Temporal Expression of Hox Genes in Polycomb-M33-Deficient Mice  by Bel-Vialar, Sophie et al.
t
o
a
e
c
i
f
t
g
t
Developmental Biology 224, 238–249 (2000)
doi:10.1006/dbio.2000.9791, available online at http://www.idealibrary.com onAltered Retinoic Acid Sensitivity and Temporal
Expression of Hox Genes in Polycomb-M33-
Deficient Mice
Sophie Bel-Vialar, Nathalie Core´, Re´mi Terranova, Veronica Goudot,
Annie Boned, and Malek Djabali1
Centre d’Immunologie, INSERM/CNRS, Case 906, 13288 Marseille Cedex 9, France
The Polycomb group genes are required for the correct expression of the homeotic complex genes and segment specification
during Drosophila embryogenesis and larval development. In mouse, inactivation studies of several Polycomb group genes
indicate that they are also involved in Hox gene regulation. We have used our previously generated M33 mutants to study
he function of M33, the mouse homologue of the Polycomb gene of Drosophila. In this paper, we show that in the absence
f M33, the window of Hoxd4 retinoic acid (RA) responsiveness is opened earlier and that Hoxd11 gene expression is
ctivated earlier in development This indicates that M33 antagonizes the RA pathway and has a function in the
stablishment of the early temporal sequence of activation of Hox genes. Despite the early activation, A-P boundaries are
orrect in later stages, indicating a separate control mechanism for early aspects of Hox regulation. This raises a number of
nteresting issues with respect to the roles of both Pc-G proteins and Hox regulatory mechanisms. We propose that a
unction of the M33 protein is to control the accessibility of retinoic acid response elements in the vicinity of Hox genes
regulatory regions by direct or indirect mechanisms or both. This could provide a means for preventing ectopic
transactivation early in development and be part of the molecular basis for temporal colinearity of Hox gene
expression. © 2000 Academic Press
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1INTRODUCTION
In Drosophila, the expression pattern of homeotic genes
(HOM-C) is determined by complex interactions among a
network of many regulatory genes (Morata, 1993). Once
established, the HOM-C expression domains are main-
ained by two antagonist groups of genes: The trithorax
roup (trx-G) sustains the activity of the homeotic genes in
he appropriate segments whereas the Polycomb group
(Pc-G) maintains the repression of the same target genes in
the cognate segments (Kennison, 1995).
In vertebrates, Hox genes are organized in four homolo-
gous clusters and are expressed starting from gastrulation in
characteristic overlapping patterns in the developing em-
bryo (Gaunt, 1988; Graham, 1989; Dressler, 1989). There is
a strict correlation between the 39 to 59 order of the Hox
genes in the complexes and their boundaries along the
1 To whom correspondence should be addressed. Fax: (33)4 91 26
m94 30. E-mail: djabali@ciml.univ-mrs.fr.
238ntero-posterior axis of the developing embryo, both in the
omatic mesoderm and in the neurectoderm (spatial colin-
arity) (Dolle et al., 1989; Duboule and Dolle, 1989; Wilkin-
on et al., 1989). In addition, Hox genes are successively
ctivated according to a temporal sequence, the 39 genes
eing expressed first, followed by more 59 genes (temporal
olinearity) (Dolle et al., 1989; Gaunt and Strachan, 1996;
zpisua-Belmonte et al., 1991). This ordered expression
attern leads to the proposal of a “Hox code” used to specify
he identity of each vertebral segment, in the same way that
OM-C genes specify the segmental identity in Drosophila
Krumlauf, 1993). The functional evidence for a Hox code
as been supported by inactivation and gain-of-function
xperiments. Hox gene misregulation results in phenotypic
efects that are restricted to the most anterior part of the
xpression domain (Favier and Dolle, 1997; McGinnis and
rumlauf, 1992; Gaunt et al., 1989; Ramirez-Solis et al.,
993).
Upstream regulatory factors, accounting for the establish-
ent of these Hox boundaries, have begun to be identified.
0012-1606/00 $35.00
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239Retinoic Acid in Hox Gene ExpressionSome of them, like the Kreisler or the Krox-20 genes are
ranscription factors specifically involved in the activation
f some selected Hox genes in the hindbrain (Manzanares et
l., 1997; Nonchev et al., 1996; Sham et al., 1993). Other
actors, like retinoic acid (RA), seem to act in a more
leiotropic way on Hox gene regulation (Marshall et al.,
996; Mavilio, 1993). Several studies have shown that Hox
enes are regulated by retinoids, such as RA, both in vivo
nd in vitro as RA administration leads to strong effects
oth on development and on cell differentiation (Conlon
nd Rossant, 1992; Simeone et al., 1990). Indeed the admin-
stration of excess retinoic acid to developing mice embryos
as significant effects on axial patterning and specification
f a number of structures, including the hindbrain, limbs,
nd axial skeleton (Kessel and Gruss, 1991). Moreover,
hese effects are accompanied by resetting the Hox gene
xpression domains (Conlon and Rossant, 1992; Kessel,
992; Marshall et al., 1992). Interestingly, Hox genes show
colinear response to retinoids in cell culture and can
espond differentially, in a time-dependent manner, to in
ivo RA treatment starting at Days 7–7.2 dpc, each Hox
ene presenting a restricted window of sensitivity to RA
Conlon and Rossant, 1992; Morrison et al., 1997). The
dentification of retinoic acid response elements (RAREs) in
ox regulatory regions that confer inducibility in trans-
enic mice has resulted in the hypothesis that RAREs and
etinoic acid receptors (RARs) may participate in the acti-
ation of Hox gene expression (Dupe et al., 1997; Langston
nd Gudas, 1992; Marshall et al., 1994; Morrison et al.,
996) and in the mechanism of spatial and temporal colin-
arity (Core et al., 1997). To date, however, despite the
ritical role of Hox genes in segmental patterning, little is
nown on how the precise boundaries of Hox expression are
stablished and what are the molecular mechanisms under-
ying the temporally coordinated expression of this com-
lex.
Yet, recent evidence suggests that the maintenance of
ox gene expression domains may be achieved by mecha-
isms that are conserved from flies to vertebrates. Once
ctivated, Hox gene expression is sustained in part by auto-
nd/or cross-regulatory mechanisms (Gould et al., 1997;
aconochie et al., 1997) and by the action of the trx-G and
c-G genes (Gould, 1997; Schumacher and Magnuson,
997), and Refs. therein). Upon targeted mutation of the
ouse trithorax homologue, expression of at least two Hox
enes (Hoxa7 and Hoxc9) is lost by Day 10.5 dpc, leading to
evelopmental arrest (Yu et al., 1995). However, in these
ice, the initiation of Hox gene expression is normal at
astrulation and early stages (Yu et al., 1998), demonstrat-
ng that the trithorax gene function is required for Hox gene
aintenance, as is the case in Drosophila.
Several mouse Polycomb group genes have been isolated
nd in Pc-G mutant mice the anterior limit of some Hox
ene expression is shifted anteriorly leading to posterior
ransformations (Alkasaka et al., 1996; Core et al., 1997;
akihara et al., 1997; van der Lugt et al., 1996; van der Lugt
t al., 1994). For example, the absence of bmi-1 function 1
Copyright © 2000 by Academic Press. All rightffects the position of the expression boundaries of a subset
f Hox genes (e.g., Hoxc-8; Hoxc-5, and Hoxc-6), from
ifferent clusters, in the somitic mesoderm from at least
he 22 somites stage. Similarly, in Mel18- and Rae28-
eficient mice, several Hox gene expression domains are
hifted anteriorly by one segment. It is interesting to note
hat each Pc-G gene regulates common and specific subsets
f Hox genes. This reveals that Polycomb complexes differ-
ng in their protein composition exist and have different
ffinities for specific Hox genes or, alternatively, that the
ack of one constituent in the complex modifies the affinity
or specific target genes (Bel et al., 1998). On the other hand,
ransgenic mice overexpressing the bmi-1 gene present a
ose-dependent anterior skeletal transformations, associ-
ted to a posterior shift in Hox boundaries, demonstrating
hat the Pc-G proteins act in mammals as in Drosophila in
dose-dependent manner (Alkema et al., 1995; Bel et al.,
998).
We have previously shown that in Pc-G M332/2 mutant
ice, except for the Hoxa3 gene, no shift of Hox gene
xpression domain was observed. Even in the case of
oxa3, the determination of the relative anterior limit of
xpression was uncertain, as the reference vertebral struc-
ure (atlas-exoccipital) used to assign the limit was already
odified at 12.5 dpc (Core et al., 1997). However the
keletal defects in the M33 mutant mice are similar to Hox
ene gain-of-function phenotypes. It has been proposed that
ot only spatially limited expression of Hox genes but also
heir strict sequential temporal activation are stringently
equired for normal development. Thus, a slight delay in
ox gene expression cannot be compensated and leads to
keletal malformations (Zakany et al., 1997). It is therefore
ossible that the skeletal defects seen in M332/2 are due to
temporal defect in the activation of the Hox genes. It is
lso possible that the M332/2 phenotype is due to a
isregulation of Hox gene expression through a defect in
he retinoic acid signaling pathway. Thus, M33 could be
mplicated in the establishment of Hox gene expression
ather than simply maintaining the correct A-P limits.
ecent experiments suggest that colinearity could be re-
ated, in part, to a higher order regulatory mechanism acting
ver the Hox complexes that control the transcriptional
ccessibility of Hox genes (Kondo et al., 1998). The Pc-G
ould be involved in this process by acting on chromatin to
ontrol the accessibility status of Hox gene regulatory
egions.
In this study, we show in M33 mutant mice, both that the
A sensitivity of Hoxd4 gene is modified and that the onset
f Hoxd11 expression is starting earlier in M33 mutant
mbryos. This suggests that M33 has a function in the
stablishment of the early temporal regulation of Hox genes
n mice, which is not the case in Drosophila. These changes
re then likely to induce the morphological alterations seen
n the M332/2 mice. This emphasizes the critical need for
correct temporal coordination of Hox gene expression for
esoderm patterning (Gerard et al., 1997; Zakany et al.,997). We propose a model for the function of the M33
s of reproduction in any form reserved.
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240 Bel-Vialar et al.protein in the temporal regulation of Hox genes, whereby
control of the accessibility of the RAREs and/or some of the
RARs cofactors provides a means of controlling the precise
timing of transactivation early in development.
MATERIALS AND METHODS
Mice and skeletal analysis. The generation of M332/2 mice
has already been described (Core et al., 1997). In timed pregnancies,
the appearance of a vaginal plug was taken as 0.5 dpc. Whole-
mount skeletons of 17.5 dpc animals were stained as described
(Conlon and Rossant, 1992). Briefly, embryos were dissected, fixed
in EtOH for 6–8 h, and then incubated in Alcian blue overnight.
Tissues remaining were digested by incubation in 2% KOH 3–4 h.
Coloration of bone was achieved using Alizarine Red in 1% KOH
for 1 day. Skeletons were kept in EtOH:glycerol, 50:50.
Retinoic acid treatment. In these experiments M336 heterozy-
gous males and females were mated for 2 h and then separated. All
trans-retinoic acid (Sigma) was kept as a 25 mg/ml stock solution
in DMSO and then diluted 1/5 in vegetable oil, and 100 I was
administered to pregnant females by gavage at 6.5, 8.5, or 9.5 dpc at
a final dose of 25 mg/kg (previously described by Colon and
Rossant, 1992). Embryos were delivered 4 or 24 h after the gavage
and somite-matched for Hox in situ analysis and delivered at 17.5
dpc for skeletal analysis. Genotypes were determined with DNA
extracted from skin by PCR analysis.
Whole-mount RNA in situ hybridization. Whole-mount em-
bryos were fixed in 4% paraformaldehyde. Hybridizations were
performed with digoxigenine-labeled probes as described in (Hen-
TABLE 1
Skeletal Malformations in M33 Mutant Mice after RA Treatment
RA treatme
1/1 1
ephalic region
Basioccipital-exoccipital fusion 0/4 0
Split in the basioccipital bone 0/4 0
ervical region
Additional arch-like structure on
the exoccipital-atlas fusion
0/4 0
Transformation C6 to C7
1 side 0/5 0
Both sides — —
Extra rib on C7 — —
Transformation C7 to T1 — —
horacic region
7 vertebrosternal ribs 4/4 7
6 vertebrosternal ribs 0/4 0
6 1 additional defects**b 0/4 0
Unilateral transformation T13 to L1 — —
Note. Summary of skeletal preparations of 17.5 dpc embryos afte
umber of altered skeletons/number of skeletons analyzed for eac
a Ribs from T1 and T2 are fused unilaterally in two heterozygot
b Corresponds to varying phenotypes including multiple rib fusirique et al. (1995). Genotypes were determined from yolk sac DNA
Copyright © 2000 by Academic Press. All rightusing PCR analysis. The following probes were used: Hoxd4 probe,
the full cDNA from D.Duboule; Hoxd11 probe, a 300-bp BamHI-
HindIII fragment containing the Hbox and part of the 39-
untranslated region from P.Dolle´. In this study, the determination
of expression to specific somite boundaries was established by a
careful count of somite numbers and the position relative to the
limb bud, with a reference to the anterior margin which is s8/9 at
9.5 dpc.
RESULTS
Enhanced Skeletal Defects in M33 Mutant Mice
Treated with All-trans Retinoic Acid at 6.5 Days
of Development
We have previously shown that administration of reti-
noic acid at 7.5 dpc enhances the skeletal malformations
observed mostly in the cervical and thoracic regions of
M332/2 mutant mice (Core et al., 1997). This result
suggested that M33 might modify retinoid signaling re-
quired to establish expression of Hox genes. We have
extended this study in order to determine precisely the
effects of RA at 7.5 dpc on skeletal homeotic transforma-
tions (Table 1). Moreover to further assess the timing of the
RA sensitivity, we administered RA to the progeny of
M336 intercrosses at 6.5 dpc, a stage at which RA has no
effect on the morphogenesis of wild-type embryos (Kessel
6.5 dpc RA treatment at 7.5 dpc
2/2 1/1 1/2 2/2
0/5 0/9 0/11 6/14
5/5 0/9 0/11 14/14
5/5 1/9 1/11 10/14
5/5 0/9 0/11 1/14
— 0/9 0/11 3/14
— 0/9 0/11 2/14
— 0/9 0/11 3/14
0/5 9/9 8 1 3a/11 0/14
4/5 0/9 0/11 9/14
3/5 0/9 0/11 5/14
— 0/9 0/11 3/14
treatment at 6.5 or 7.5 days of gestation. The values indicate the
otype.
he third animal presents an unwedge junction of the ribs.
unwedge junctions, and reduced number of sternebras.nt at
/2
/7
/7
/7
/5
/7
/7
/7
r RA
h gen
es. Tand Gruss, 1991) (Table 1).
s of reproduction in any form reserved.
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The administration of RA (40 mg/kg) at 6.5 dpc does not
perturb the development of wild-type embryos. Careful
examination of skeletal preparations of wild-type and
M336 mice does not reveal any alterations (Fig. 1A, a, b,
and not shown). However skeletal preparations of RA-
treated mutant mice display systematic aggravations of the
M332/2 malformations, with varying degrees of severity
(Fig. 1A, c and d). RA-treated M332/2 mice have a split in
the exoccipital-atlas structure, resembling additional neu-
ral arches anterior to the exoccipital-atlas fusion (Fig. 1A,
d). The basioccipital bone is also affected, as it presents a
split in the anterior region, and a bilateral crescent-shape
extension, which is nearly fused to the exoccipital bone
(Fig. 1B, d). These modifications are never seen in the
nontreated mutant mice (Fig. 1B, b) or in the treated
wild-type mice (Fig. 1B, c) (Table 1).
Thoracic Region
The treatment at 6.5 dpc induces additional malforma-
tions in the sternebral region of M332/2 mice, again with
varying severity. The most striking abnormality is that
sternovertebral ribs are fused before joining the manubrium
sterni leading to 5 sternovertebral ribs in the RA-treated
mutant mice (Fig. 1C, d) instead of 6 in nontreated mutant
mice (Fig. 1C, b). These modifications are not detected in
wild-type treated mice (Fig. 1C, b) (Table 1).
This enhancement of M332/2 skeletal malformations
fter RA treatment indicates that RA can already act at this
tage in M332/2 mice, raising the possibility that, in the
bsence of the M33 product, some Hox genes are ectopically
activated at 6.5 dpc.
Hoxd4 RA Sensitivity Is Altered in M332/2
Embryos
In order to evaluate whether the skeletal defects pro-
voked by RA treatment in mutant mice were correlated to
modifications in Hox gene regulation, we analyzed the
effects of RA treatment on Hoxd4 gene expression in
M332/2 mutant mice and controls.
Hoxd4 cis-regulatory regions that generate correct bound-
aries for both mesoderm and neurectoderm have been
extensively characterized (Morrison et al., 1996, Morrison
et al., 1997; Zhang et al., 1997). The murine Hoxd4 gene
contains a 59 RARE which is required to recapitulate the
endogenous expression in the CNS in transgenic mice
(Morrison et al., 1996). In those studies, it has been shown
using transgenic analysis that the Hoxd4 gene does not
respond to RA treatment until 9.0–9.5 dpc. However recent
studies have demonstrated that the endogenous Hoxd4
gene is sensitive to RA treatment at 8.5 dpc (Folberg et al.,
1997). This difference in the window of sensitivity might be
due to the transgene characteristics or to the mice back-
ground used in the respective experiments. In order to avoid
such an effect in our background, we have treated the
Copyright © 2000 by Academic Press. All rightprogeny of heterozygous M336 crosses with RA at 7.5 dpc
in vivo (1–4 somites stage) and analyzed the expression
status of the Hoxd4 gene 6 h after the treatment (8 somites)
(see schematic representation given on top of Fig. 2). The
anterior limit of expression of Hoxd4 in treated and non-
treated wild-type embryos reaches the rhombomere 6/7
boundary in the neurectoderm and the somite 4/5 boundary
in the paraxial mesoderm (Fig. 2A, c). This corresponds to
the normal boundaries of the Hoxd4 expression pattern
already described (Gaunt et al., 1989; Hunt et al., 1991).
Similarly, the boundaries of Hoxd4 in M332/2 nontreated
embryos are correct both in the mesoderm and in the
neurectoderm (Fig. 2A, b). However, in M332/2 RA-treated
embryos, the anterior limit of expression is shifted anteri-
orly by 2 somites in the mesoderm (up to s3/4) but is not
modified in the neurectoderm (Fig. 2A, d). At this stage we
have never detected in RA-treated wild-type embryos any
anterior shift in the Hoxd4 expression boundaries (Table 2).
When the RA treatment is done later, at 8.5 dpc (10
somites stage), we also detect, 4 h after the treatment, an
anterior shift of the Hoxd4 boundaries exclusively in the
absence of M33 (Fig. 2B, b). In RA-treated mutant mice the
Hoxd4 boundary in the mesoderm is s3/4 (this corresponds
to an anterior shift of 2 somites) and reaches rhombomere
5/6 in the neurectoderm (r5/6) (Fig. 2B, b). These results
indicate that the absence of M33 allows the premature
activation of Hoxd4 by RA as early as the 4 somites stage.
However when RA treatment is done at 7.5 dpc the anterior
shift is only detected in mesodermal tissues indicating that
at this age M33 product has a differential control on
promoter elements driving the expression of the Hoxd4
gene in mesodermal and neurectodermal tissues, respec-
tively.
The RA Response Is Sustained over Time
In order to determine if the response to RA in M332/2
embryos was sustained over time, 8.5 dpc treated embryos
were analyzed 24 h after RA treatment. As seen in Fig. 2C,
the anterior shift of Hoxd4 boundaries is still visible 24 h
after the treatment. Indeed, in the neurectoderm, the
boundary reaches the otic vesicle in all the treated mutant
embryos and in the paraxial mesoderm the anterior limit is
shifted by two somites (up to s3/4) (Fig. 2C, d). This result
implies that in the absence of the M33 protein, the rapid
RA-induced Hoxd4 shift is sustained over a 24-h period.
In all these experiments, the change of the Hoxd4 ante-
rior boundary following 7.2 to 8.5 dpc RA treatment in
M332/2 mice indicates a time shift in the competence of
Hoxd4 to respond to ectopic RA.
In double PcG mutant mice (Bel et al., 1998) we have
previously shown that the Hoxc9 gene was anteriorized in
mesodermal tissues; therefore, we also have tested the
response of the Hoxc9 gene to RA at different times both in
wild-type and M33 mutant mice. However, this gene is
insensitive to the absence of the M33 product and no
s of reproduction in any form reserved.
(c). (B) The shape of the basioccipital bone is changed in M332/2 (b)
242 Bel-Vialar et al.
Copyright © 2000 by Academic Press. All rightanteriorization of its expression was detected upon RA
treatment (data not shown).
Precocious Expression of the Hoxd11 Gene
The early sensitivity to RA administration at 6.5 dpc
and the premature response of the Hoxd4 gene to RA
treatment raise the possibility that the absence of M33
protein allows an earlier activation of Hox genes. To
assess this possibility, we have analyzed the expression
of a posterior gene in the HoxD complex in M332/2
embryos. The Hoxd11 gene is one of the most 59 genes in
the cluster and its expression normally starts in the
allantois by 8.5 dpc (Izpisua-Belmonte et al., 1991). We
checked its expression boundaries at 8.5–9.5 dpc in
M33-deficient versus wild-type mice. At the 14 somites
stage, Hoxd11 RNA accumulation in wild-type embryos
is never detected (Figs. 3a and 3c) whereas its expression
is clearly detected in the presomitic mesoderm in mutant
embryos (Figs. 3b and 3d). At a later stage (27 somites),
mutant embryos display a stronger accumulation of the
Hoxd11 transcripts with an extended expression domain
in the mesoderm and in the neural tube as compared to
the wild-type embryos (Figs. 3 e– g). This reflects the
temporal advance of Hoxd11 expression at this stage.
Although there is an extended spatial domain of expres-
sion of Hoxd11 until the 27 somites stage in M332/2
mice, the boundaries appear to be identical both in M33
mutants and in wild-type embryos later in development
(35 somites stage, not shown). This result points out that
M33 is dispensable for the control of Hoxd11 expression
in the late stages of development and that other factors
are then responsible for setting the anterior boundary of
this gene (Gould et al., 1997; Maconochie et al., 1997).
DISCUSSION
In this paper we showed that M332/2 mutant mice have
abnormal sensitivity to RA treatment at 6.5 dpc, resulting
in increased severity of the skeletal defects. In M332/2
compared to a wild type (a). Moreover, RA treatment enhances this
M332/2 defect since the basioccipital bone is now nearly fused to
the exoccipital-atlas structure (d, arrow). No defect of the basioc-
cipital bone is seen in the wild-type treated mice (c). (C) As already
described, the sternebral region is affected in M33-deficient mice
since 6 ribs are attached to the sternum (b) instead of 7 in a wild
type (a). In M332/2 RA-treated mice additional defects are seen: In
(d), T4 and T5 are fused together before joining the manubrium
sterni (arrow) leading to 5 sternovertebras instead of 6 in nontreated
mutant mice (b). Such defects were never seen in 6.5 dpc RA-
treated wild-type mice (a). (C1) The atlas, (C2) the axis, (ex)
exoccipital bone, (ba) basioccipital bone, (T) thoracic rib, (*)FIG. 1. Skeletal malformations in M332/2 RA-treated embryos
and controls. RA treatment was at 6.5 dpc and embryos were
collected at 17.5 dpc for skeletal analysis. (A) In the cervical region
of a wild type, only the atlas (C1) has an anterior arch (a). As already
described, in M332/2 the atlas is fused to the exoccipital bone (b).
The RA-treated M332/2 mice now exibit a split of the exoccipital-
atlas structure (*), resembling an additional neural arch (d, arrow)
whereas RA treatment has no effect on the wild type at this stageexoccipital-atlas fusion.
s of reproduction in any form reserved.
243Retinoic Acid in Hox Gene ExpressionFIG. 2. Expression of Hoxd4 under 7.5 dpc RA treatment in M332/2 mutant mice. (A) RA treatment was done by oral gavage at the 4
somites stage (7–7.5 dpc; see schematic protocol drawn above Fig. 2A; the thin arrows represent time of RA treatment for each experiment;
time of observation is depicted by the large arrows; red arrow is for experiment A, blue experiment B, and green experiment C) and embryos
were collected 6 h later (8 somites stage). The Hoxd4 boundaries are already established at this stage, up to r6/7 in the neural tube and up
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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244 Bel-Vialar et al.embryos, the Hoxd4 gene has a premature competence in
he ability to respond to RA, both in mesodermal and in
eurectodermal tissues. This suggests a role for M33 in
oordinating information from the RA signaling pathway in
arly mouse development. In addition, the early expression
f Hoxd11 is temporally affected in M332/2 embryos. This
illustrates that M33 may have a function in the establish-
ment of early Hox gene expression as opposed to a Pc-G
maintenance function in Drosophila (Kennison, 1995) and
that the temporal difference in the competence of specific
Hox genes to respond to RA is controlled in part by M33.
Skeletal Transformations Are Aggravated
in RA-Treated M33-Deficient Mice
RA treatment of embryos starting at gastrulation leads to
strong skeletal homeotic transformations, accompanied by
resetting the Hox gene expression domains (Conlon and
Rossant, 1992; Kessel, 1992; Kessel and Gruss, 1991). How-
ever, wild-type mice treated at 6.5 dpc are refractory to
those skeletal transformations and to modifications in the
Hox pattern of expression (Kessel and Gruss, 1991). We
have shown that all the M332/2 mice treated at 6.5 dpc
present additional transformations in the cervical and in
the thoracic regions, suggesting that M33 might be involved
in some aspects of the RA signaling pathway. Interestingly,
to s4/5 in the somitic mesoderm (a, WT, arrows). The RA treatm
utant embryos (b, pink arrow). Note that the neurectoderm boun
as performed by oral gavage at the 10 somites stage and the emb
mbryos, the boundaries of Hoxd4 expression are r6/7 in the ne
oundaries are not changed either in RA-treated wild-type embryo
on M332/2 leads to a one segment anterior shift both in the somit
as done at 8.5 dpc and embryos were collected 24 h later (a, 9.5
xpression at 9.5 dpc than at 8.5 dpc (a, black arrows). These bou
reatment has no effect on wild-type mice at this stage of devel
xpression under RA treatment is still visible in the M332/2 muta
ABLE 2
nterior Limit of Expression of Hoxd4 in M33 Mutant Mice after
RA treatment Embryo collection
4 somites 8 somites
10 somites (8.5 dpc) 12 somites
8.5 dpc 25 somites
Note. Summary of wild-type (WT) and mutant (M332/2) embryo
RA treatment. The somite number indicates the stage at which the
for in situ hybridization with Hoxd4 (large arrows on top of Fig. 2
a Anteriorization was only seen in the mesoderm.
b Anteriorization was seen in both the mesoderm and the neuret least 24 h. (ov) Otic vesicle, (s) somite, and (r) rhombomere.
Copyright © 2000 by Academic Press. All righthe phenotype in the cervical region is clearly reminiscent
f transgenic mice overexpressing the Hoxd4 gene under
he Hoxa1 promoter (Lufkin et al., 1992). These mice
isplay homeotic transformations of the occipital bones
oward a more posterior phenotype into structures that
esemble cervical vertebras. Although the transgenic con-
truction allows the Hoxd4 gene to be expressed in the
ore anterior region, it is also interesting to note that it
llows the Hoxd4 gene to be expressed earlier during
evelopment, as the promoter is derived from the Hoxa1
ene situated in a more 39 position in the complex. Hence,
n these transgenic experiments, the homeotic transforma-
ions might also be due in part to a defect in the timing of
oxd4 expression. Similarly, in the RA-treated M332/2
ice, the enhanced skeletal defects might reflect a tempo-
al shift in the expression of some Hox genes, inducing
igher levels at early stages, resulting in altered skeletal
orphogenesis.
The Hoxd4 Gene Has a Premature Competence
to Be Activated by RA in M332/2
In M332/2 mice, Hoxd4 is sensitive earlier to exogenous
RA treatment compared to wild-type mice. Among the
three group 4 genes (Hoxa4, b4, and d4), separate transcrip-
tional enhancers, situated in the vicinity of the open-
lready induces a one segment shift in the mesoderm of M332/2
is not affected by the RA treatment at this age. (B) RA treatment
were collected 4 h after treatment (12 somites stage). In wild-type
tube and s4/5 in the somitic mesoderm (a, black arrows). These
or in M332/2 embryos (b, black arrows). However, RA treatment
esoderm and in the neural tube (d, pink arrows). (C) RA treatment
25 somites stage). The Hoxd4 gene keeps the same boundaries of
ies are not changed in a M332/2 context (b). Similarly, the RA
ent (c, black arrows, see also (27)). The anterior shift of Hoxd4
, pink arrows) indicating that the RA-induced shift is sustained for
reatment
WT M33
2RA 1RA 2RA 1RA
0/10 0/7 0/8 6/6a
0/7 1/9a 0/4 7/8b
0/11 0/6 1/9a 7/7b
which the Hoxd4 anterior limit of expression is anteriorized upon
ryos where treated by RA (thin arrows on top of Fig. 2) or harvested
rm.ent a
dary
ryos
ural
s (c)
ic m
dpc,
ndar
opem
nt (dRA T
s for
emb
).s of reproduction in any form reserved.
a
a
o
e
s
F
e
s
o
p
t
1
T
g
t
t
o
a
M
s
g
245Retinoic Acid in Hox Gene Expressionreading frames, control Hox expression in the mesoderm
nd in the neurectoderm (Morrison et al., 1997; Zhang et
l., 1997). Using transgenic analysis, it was shown that two
f these enhancers are neurectoderm specific and respond to
xogenous RA, whereas two other enhancers are mesoderm
pecific and do not present any response to RA treatment.
urthermore, comparative analysis of the neurectodermal
nhancers shows that, for all of these enhancers, there is a
imilarly restricted temporal window of sensitivity to ex-
genous retinoids, around 8.5 to 9.5 dpc (15 somites stages),
robably depending on the mouse genetic background since
his window is 8.5 dpc in a CD1 background (Folberg et al.,
997) and 9.5 dpc in a 129 sv/BalbC background (our study).
his temporal window opens later than that for more 39
enes such as Hoxb1 or Hoxa1, indicating that there is a
emporal colinearity of sensitivity to exogenous RA and
hat the competence to be activated depends on the position
f Hox genes on the cluster (Conlon and Rossant, 1992). In
M33 mutant background, the Hoxd4 gene becomes com-
petent to activation by RA in a time window corresponding
in the wild type to more anterior genes. This suggests that
the M33 product maintains directly or indirectly, both
mesodermal and neurectodermal defined enhancers in a
“closed” state (that is, insensitive to RA) until Days 9–9.5
dpc. As previously suggested, this temporal colinear re-
sponse to RA does not require a graded concentration of
retinoids along the antero-posterior axis as previously sug-
gested (Dekker et al., 1992; Gaunt and Strachan, 1994). We
propose that the molecular basis of the temporal window of
sensitivity to RA is due in part to the Pc-G gene products
controlling directly or indirectly the response to RA and, thus,
the pattern of Hox gene expression. This could be mediated by
the ability of M33 to alter the levels or the activity of retinoid
receptors which then directly impairs activation of Hox genes,
or by controlling the accessibility of trans-acting factors to the
Hox genes by chromatin mechanisms.
Hoxd11 Is Expressed Earlier in M332/2 Mice
In the absence of repression through the Pc-G product
33, the Hoxd11 gene is expressed earlier in development
howing that M33 control the establishment phase of Hox
enes expression. This is in contrast with the rule of Pc-G
in Drosophila, which are known to be involved in the
maintenance of the HOM-C gene expression pattern during
the late stages of development. The fact that the absence of
M33 does not alter the pattern of expression at late stages,
i.e., 12.5 dpc, indicates separate control mechanisms for
early and late aspects of Hox regulation. It seems that
vertebrate Pc-G proteins are implicated not only in the
maintenance but also in the activation of Hox expression.
Different Pc-G complexes, showing different affinities for
different Hox regulatory regions controlling early or late
Hox expression, could achieve these different functions.
Moreover, Hox genes are able to control their own expres-
sion by cross- and autoregulatory mechanisms (Gould et al.,
Copyright © 2000 by Academic Press. All right1997; Maconochie et al., 1997) and this regulatory mecha-
nism could subsidize in part to Pc-G maintenance in
vertebrates.
Pc-G May Be Involved in the Control of Temporal
Colinearity of Hox Expression
Several mechanisms have been proposed to explain the
evolutionary conservation of the clustered organization
and the spatial and temporal expression pattern of the
Hox genes in vertebrates. A clustered organization is
probably required for the sharing of cis-acting regulatory
elements and for sharing a general enhancer sequence
that controls the expression of several genes within the
cluster (Gerard et al., 1996, 1997). However, it has been
suggested recently, given the effects of transposition of
HoxD genes to ectopic positions within the same com-
plex, that a repressive mechanism exists and may act to
prevent premature activation of posterior genes. This
study demonstrates a position-dependent mechanism
controlling the timing of expression of Hox genes (van der
Hoeven et al., 1996). Moreover the transposition of
Hoxd9 to a more 59 position in the D complex resulted in
a transient delay in transcription (van der Hoeven et al.,
1996). Recent data have demonstrated that the correct
timing of expression of the Hoxd11 and Hoxd10 genes
during early somitogenesis was critical for a proper
vertebral specification and that a delay in expression
(transcriptional heterochrony) cannot be compensated
and leads to morphological alterations (Duboule, 1994;
Zakany et al., 1997).
Our data, together with experiments transposing Hox
genes in the complex or deleting enhancers on the D
complex (van der Hoeven et al., 1996; Zakany et al., 1997),
strongly suggest that Hox complexes are first refractory to
transcription early in development and then gradually ac-
cessible to transcription factors, and that the Pc-G genes
have a function in this repression mechanism. Therefore it
is likely that the Pc-G gene products have a role in modu-
lating a temporal colinearity of expression along the Hox
gene complexes.
We favor the model shown in Fig. 4, that proposes each
gene within a cluster would show a graded sensitivity to RA
through a repression imposed by Pc-G genes: with 39 genes
being accessible earlier than the adjacent 59 gene. This
differential repression contributed by M33 can be hypoth-
esized since, in two different backgrounds in M332/2
mice, the skeletal transformations are found more fre-
quently in the anterior (due to the deregulation of more 39
Hox genes) than in the posterior regions (Core et al., 1997).
This would imply that the Pc-G repression is more depen-
dent on the M33 product at the 39 end of the cluster than at
the 59 end, or/and that the nature of the complex may vary
from the 39 end to the 59 end of a Hox cluster. This
repression could again be mediated by direct or indirect
mechanisms.
s of reproduction in any form reserved.
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An important question concerning retinoid receptor func-
tion was to understand the mechanism by which nuclear
receptors mediate activation or repression while remaining
bound to their response elements on DNA. It has been
shown recently that corepressor or coactivator recruitment
is dependent on the presence of the ligand (RA), allowing a
switch from activation to repression by the exchange of
complexes containing histone deacetylases with those that
have histone acetylase activity (Hassig et al., 1997; Torchia
FIG. 3. Expression of Hoxd11 in M332/2 mutant mice. Hoxd1
embryos (WT, a,b). At the same somite stage, the expression is detec
(b,d, arrow) (3/3 mutants embryos , one not shown, present this pre
In mutant embryos the expression domain is more extended at th
(arrowheads) (6/9 embryos).et al., 1997). This provides a molecular link between
Copyright © 2000 by Academic Press. All rightchromatin remodeling and regulation of transcription. It
has been hypothesized that Pc-G proteins bind to specific
sites and modify the local chromatin structure to stably
repress gene transcription (Pirrotta, 1997). Indirect evidence
favors a model of the formation of a repressed state of
transcription through a chromatin configuration resem-
bling heterochromatin. The Pc protein shares a motif of
approximately 40 amino acids (chromo domain) with the
Su(var)205 gene product HP1, a heterochromatin constitu-
ent (Singh et al., 1991). Mutation in HP1 suppresses posi-
not expressed at the 14 somites stage in two different wild-type
n the posterior lateral mesoderm in two different M332/2 embryos
us expression). Hoxd11 expression at the 27 somite stage embryos.
age (e–g) both in the lateral mesoderm and in the neurectoderm1 is
ted i
cocio
is sttion effect variegation through heterochromatinization
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247Retinoic Acid in Hox Gene Expression(Singh, 1994). It has been proposed that Pc and Pc-G
proteins could function analogously by structuring chroma-
tin configuration (Orlando and Paro, 1993, 1995; Pirrotta,
1997a). The finding that RA might participate in the regu-
lation of colinear expression of Hox genes along the A-P
axis and the identification of RAREs in the promoter
regions of Hox genes (see introduction) suggests that reti-
noic acid receptors might mediate Hox gene regulation of
expression. Moreover, inactivation of RARs results in mice
in defects similar to those obtained by Hox loss-of-function
FIG. 4. Potential regulation mechanism of the Hox gene comple
is in a “closed” status. The Pc-G multimeric complex (triangle a
genes (dark rectangles). In this scheme the repression through t
complex since single Polycomb mutant mice more often show
ransformations. The 39 genes are more sensitive to RA than 5
roteins (circles) are dissociated from the complex and/or the pr
chieved up to the 39 end of the complex, allowing anterior genes
e.g., RARs and RA). M332/2 mutant situation: At 6.5 dpc, due t
on the 39 end of the complex and “anterior” genes are already sen
The progressive opening of the complex allows a sequential activ
earlier compared to the control.mutations (Kastner et al., 1995), implying that Hox gene
Copyright © 2000 by Academic Press. All rightxpression is controlled by retinoids during normal devel-
pment in mice.
Our results with M332/2 mice on the alteration of the
oxd4 gene competence in response to RA treatment
ropose that members of the Pc-G proteins might be
ssociated with RARs, corepressor complexes, and
eacetylase activity, providing a possible functional link
etween Pc-G products and chromatin remodeling. Re-
ently it has been shown in Drosophila that dMi-2 was
unctionally linked to Pc repression (Kehle et al., 1998).
y the Pc-G proteins. Wild-type situation: At 6.5 dpc the complex
the complex) is acting to prevent ectopic activation of the Hox
c-G gene products is drawn as more effective 59 than 39 in the
rior skeletal alterations with a higher frequency than posterior
nes (RA sensitivity gradient). At 7.5 dpc, repressive Polycomb
concentration is rate limiting. Thus, the repression can not be
e progressively transcribed through the action of transactivators
absence of M33 product, the repressive complex is not effective
e to RA and transcribed, inducing a shift in temporal colinearity.
of Hox genes, as in a normal context, but each gene is accessiblexes b
bove
he P
ante
9 ge
otein
to b
o the
sitiv
ationIn Xenopus, Mi-2 has been shown to be a subunit of a
s of reproduction in any form reserved.
d248 Bel-Vialar et al.deacetylase complex. All together, these results strongly
suggest that Pc-G silencing is mediated through histone
eacetylation and changes in chromatin structure.
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